133 related articles for article (PubMed ID: 37054506)
1. Estrogen induces genomic instability in high-risk HPV-infected cervix and promotes the carcinogenesis of cervical adenocarcinoma.
Ogawa M; Hashimoto K; Kitano S; Yamashita S; Toda A; Nakamura K; Kinose Y; Kodama M; Sawada K; Kimura T
Biochem Biophys Res Commun; 2023 Jun; 659():80-90. PubMed ID: 37054506
[TBL] [Abstract][Full Text] [Related]
2. Requirement of estrogen receptor alpha DNA-binding domain for HPV oncogene-induced cervical carcinogenesis in mice.
Son J; Park JW; Lambert PF; Chung SH
Carcinogenesis; 2014 Feb; 35(2):489-96. PubMed ID: 24148821
[TBL] [Abstract][Full Text] [Related]
3. ERa-36 instead of ERa mediates the stimulatory effects of estrogen on the expression of viral oncogenes HPV E6/E7 and the malignant phenotypes in cervical cancer cells.
Zhang X; Zhang A; Zhang X; Hu S; Bao Z; Zhang Y; Jiang X; He H; Zhang TC
Virus Res; 2021 Dec; 306():198602. PubMed ID: 34662680
[TBL] [Abstract][Full Text] [Related]
4. Requirement for estrogen receptor alpha in a mouse model for human papillomavirus-associated cervical cancer.
Chung SH; Wiedmeyer K; Shai A; Korach KS; Lambert PF
Cancer Res; 2008 Dec; 68(23):9928-34. PubMed ID: 19047174
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis.
Elson DA; Riley RR; Lacey A; Thordarson G; Talamantes FJ; Arbeit JM
Cancer Res; 2000 Mar; 60(5):1267-75. PubMed ID: 10728686
[TBL] [Abstract][Full Text] [Related]
6. WAPL induces cervical intraepithelial neoplasia modulated with estrogen signaling without HPV E6/E7.
Kumagai K; Takanashi M; Ohno SI; Harada Y; Fujita K; Oikawa K; Sudo K; Ikeda SI; Nishi H; Oikawa K; Kuroda M
Oncogene; 2021 May; 40(21):3695-3706. PubMed ID: 33947962
[TBL] [Abstract][Full Text] [Related]
7. Induction of aromatase expression in cervical carcinomas: effects of endogenous estrogen on cervical cancer cell proliferation.
Nair HB; Luthra R; Kirma N; Liu YG; Flowers L; Evans D; Tekmal RR
Cancer Res; 2005 Dec; 65(23):11164-73. PubMed ID: 16322267
[TBL] [Abstract][Full Text] [Related]
8. Molecular and pathological basis of HPV-negative cervical adenocarcinoma seen in a global study.
Jenkins D; Molijn A; Kazem S; Pirog EC; Alemany L; de Sanjosé S; Dinjens W; Quint W
Int J Cancer; 2020 Nov; 147(9):2526-2536. PubMed ID: 32474915
[TBL] [Abstract][Full Text] [Related]
9. HPV 16 E2 binding sites 1 and 2 become more methylated than E2 binding site 4 during cervical carcinogenesis.
Leung TW; Liu SS; Leung RC; Chu MM; Cheung AN; Ngan HY
J Med Virol; 2015 Jun; 87(6):1022-33. PubMed ID: 25648229
[TBL] [Abstract][Full Text] [Related]
10. Requirement for stromal estrogen receptor alpha in cervical neoplasia.
Chung SH; Shin MK; Korach KS; Lambert PF
Horm Cancer; 2013 Feb; 4(1):50-9. PubMed ID: 23065599
[TBL] [Abstract][Full Text] [Related]
11. Estrogen and progesterone receptor expression in HPV-positive and HPV-negative cervical carcinomas.
Kwasniewska A; Postawski K; Gozdzicka-Jozefiak A; Kwasniewski W; Grywalska E; Zdunek M; Korobowicz E
Oncol Rep; 2011 Jul; 26(1):153-60. PubMed ID: 21491087
[TBL] [Abstract][Full Text] [Related]
12. Development and assessment of a general theory of cervical carcinogenesis utilizing a severe combined immunodeficiency murine-human xenograft model.
Tewari KS; Taylor JA; Liao SY; DiSaia PJ; Burger RA; Monk BJ; Hughes CC; Villarreal LP
Gynecol Oncol; 2000 Apr; 77(1):137-48. PubMed ID: 10739703
[TBL] [Abstract][Full Text] [Related]
13. Low incidence of microsatellite instability in patients with cervical carcinomas.
Rodriguez JA; Barros F; Carracedo A; Mugica-van Herckenrode CM
Diagn Mol Pathol; 1998 Oct; 7(5):276-82. PubMed ID: 9990486
[TBL] [Abstract][Full Text] [Related]
14. Estrogen/GPR30 Signaling Contributes to the Malignant Potentials of ER-Negative Cervical Adenocarcinoma via Regulation of Claudin-1 Expression.
Akimoto T; Takasawa A; Takasawa K; Aoyama T; Murata M; Osanai M; Saito T; Sawada N
Neoplasia; 2018 Oct; 20(10):1083-1093. PubMed ID: 30227306
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of HPV-associated cervical carcinogenesis in formalin-fixed paraffin-embedded (FFPE) tissues using the NanoString nCounter
Balasubramaniam SD; Balakrishnan V; Oon CE; Kaur G
Gene; 2022 May; 825():146385. PubMed ID: 35288200
[TBL] [Abstract][Full Text] [Related]
16. Progesterone signaling inhibits cervical carcinogenesis in mice.
Yoo YA; Son J; Mehta FF; DeMayo FJ; Lydon JP; Chung SH
Am J Pathol; 2013 Nov; 183(5):1679-1687. PubMed ID: 24012679
[TBL] [Abstract][Full Text] [Related]
17. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.
Zielinski GD; Snijders PJ; Rozendaal L; Daalmeijer NF; Risse EK; Voorhorst FJ; Jiwa NM; van der Linden HC; de Schipper FA; Runsink AP; Meijer CJ
J Pathol; 2003 Dec; 201(4):535-43. PubMed ID: 14648656
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor localization in normal and neoplastic epithelium of the uterine cervix.
Nonogaki H; Fujii S; Konishi I; Nanbu Y; Ozaki S; Ishikawa Y; Mori T
Cancer; 1990 Dec; 66(12):2620-7. PubMed ID: 2249202
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic HPV promotes the expression of the long noncoding RNA lnc-FANCI-2 through E7 and YY1.
Liu H; Xu J; Yang Y; Wang X; Wu E; Majerciak V; Zhang T; Steenbergen RDM; Wang HK; Banerjee NS; Li Y; Lu W; Meyers C; Zhu J; Xie X; Chow LT; Zheng ZM
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33436409
[TBL] [Abstract][Full Text] [Related]
20. Significance of p53-binding protein 1 nuclear foci in uterine cervical lesions: endogenous DNA double strand breaks and genomic instability during carcinogenesis.
Matsuda K; Miura S; Kurashige T; Suzuki K; Kondo H; Ihara M; Nakajima H; Masuzaki H; Nakashima M
Histopathology; 2011 Sep; 59(3):441-51. PubMed ID: 22034884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]